Kyowa Hakko Kirin and Hisamitsu entered into a Joint Distribution Agreement on Cancer Pain Drug (Development Code: KW-2246)Joint Distribution Agreement • January 29th, 2010
Contract Type FiledJanuary 29th, 2010Kyowa Hakko Kirin Co., Ltd. (Head Office: Chiyoda-ku, Tokyo; President: Yuzuru Matsuda; hereinafter “Kyowa Hakko Kirin”) and Hisamitsu Pharmaceutical Co., Inc. (Head Office: Tosu, Saga; President: Hirotaka Nakanomi; hereinafter “Hisamitsu Pharmaceutical”) hereby announce today that they have entered into a joint distribution agreement in Japan for a cancer pain drug (development code: KW-2246), which is under development by Kyowa Hakko Kirin .